Navigation Links
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
Date:8/6/2013

NEW YORK, Aug. 6, 2013 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Columbia on behalf of investors who purchased Vanda Pharmaceuticals, Inc. ("Vanda" or the "Company") (NasdaqGM: VNDA) stock between December 18, 2012 and June 18, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

For more information, click here: http://zlk.9nl.com/vanda-pharmaceuticals-vnda/

The complaint alleges that defendants violated federal securities laws by issuing materially false and misleading statements and/or failing to disclose materially adverse facts concerning the Company's Phase III testing of the drug Tasimelteon. In particular, it is alleged that, in the middle of the Phase III studies, Vanda altered the primary endpoint to one never before used in a sleep-drug clinical trial—and not endorsed by the FDA—when data suggested the original endpoint would not be met.

On June 19, 2013, an article was published on thestreet.com, questioning the efficacy of Vanda's study, noting that the study not only changed multiple times, but that it replaced the primary endpoint just a month before study results were announced. On the news, shares of Vanda closed at $8.51 per share on June 19, 2013, a drop of more than 20% from the previous day.

If you suffered a loss in Vanda you have until August 24, 2013 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (877) 363-5972, or visit http://zlk.9nl.com/vanda-pharmaceuticals-vnda/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510
www.zlk.com


'/>"/>
SOURCE Levi & Korsinsky, LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Hospira to Present at Upcoming Investor Conferences
3. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
4. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Unigenes Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
7. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
8. MDHI Provides Investor Update -- Provides Business Model Overview -- Discusses Upcoming Profitability
9. Delcath To Present At Upcoming Investor Conferences
10. Uroplasty To Participate In Two Upcoming Conferences
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... May 21, 2020 , ... On Saturday, May ... COVID-19 drive-through testing shelter in Camden County, New Jersey. The new drive-through testing ... Strong & Buckelew and is located at 3100 Federal Street, across from Woodrow ...
(Date:5/21/2020)... ... 21, 2020 , ... Today Anyblock Analytics, a German firm ... app. Many facilities, cities, states/provinces, and countries are eager to begin re-opening their ... 1.5 million in the United States alone—serious concerns remain about how to do ...
(Date:5/21/2020)... ... ... Labyrinthe Labs has announced the launch of its brand new and ground-breaking topical ... fast-action relief of joint and muscle soreness, Lefa is botanically powered by a clinically ... muscles. , According to the National Institutes of Health , approximately 25.3 ...
Breaking Medicine Technology:
(Date:5/21/2020)... ... , ... Having the cushion of an already established worldwide ... ground with the inherited reputation of quality, innovation, and professionalism. The VITA NOVAS’ ... way for the ingredients to become immediately available to the cells. This greatly ...
(Date:5/21/2020)... ... May 21, 2020 , ... The Rise of Mental Health ... a lot of complications and adjustments, needless to say, more complications. With rising deaths, ... the great depression it can be hard to escape and find peace. Adding to ...
(Date:5/16/2020)... ... May 15, 2020 , ... For patients who have gone to see Andy Gaertner, D.M.D ... has always had in place. After being allowed to re-open during the current pandemic, they ... staff are as safe and comfortable as possible while going through their dental exams and ...
(Date:5/15/2020)... ... May 15, 2020 , ... Collagen has taken the areas of beauty ... in 2019, according to a 2020 Nutritional Outlook ‘Ingredients to Watch’ US forecast. Collagen ... away from the high molecular weight, low-impact products of the past to the clinically-studied, ...
(Date:5/15/2020)... , ... May 15, 2020 , ... How do you ... unanswered. Thousands of private practice offices are not set up to see their patients. ... patient and disease history are challenging to overcome. Doctors and patients need to connect ...
Breaking Medicine News(10 mins):